SPONSOR
University College, London
Total Trials
14
Recruiting
14
Phases
Phase 2, Phase 3, Phase 1, Phase 1, Phase 2
Conditions studied: Mantle Cell LymphomaTotal Knee ReplacementTotal Knee Replacement SurgeryTotal Knee ArthroplastyOsteoarthritis (OA) of the KneeDecompensated CirrhosisBronchial AsthmaBronchiectasisILDCOPD
University College, London is a clinical research sponsor with 14 registered studies on ClinicalTrials.gov, of which 14 are actively recruiting participants. Research covers conditions including Mantle Cell Lymphoma, Total Knee Replacement, Total Knee Replacement Surgery, Total Knee Arthroplasty.
The trial portfolio spans Phase 2, Phase 3, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University College, London
How many clinical trials has University College, London sponsored?
ClinicalMetric currently tracks 14 clinical trials sponsored by University College, London, of which 14 are actively recruiting participants. These trials cover conditions including Mantle Cell Lymphoma, Total Knee Replacement, Total Knee Replacement Surgery. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University College, London research focus on?
University College, London clinical trials span Mantle Cell Lymphoma, Total Knee Replacement, Total Knee Replacement Surgery, Total Knee Arthroplasty, Osteoarthritis (OA) of the Knee, and additional conditions. The research pipeline includes Phase 2, Phase 3, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University College, London clinical trial?
To participate in a University College, London trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University College, London trials with current recruitment status updated daily.
Clinical Trials by University College, London
NCT05635162 Phase 2
Recruiting
Zanubrutinib Plus Rituximab for Patients With Indolent Mantle Cell Lymphoma
Mantle Cell Lymphoma
NCT06929871
Recruiting
Mako Cementless TKA vs Mako Cemented TKA
Total Knee Replacement
NCT06223893
Recruiting
CirrhoCare- Using Smart-phone Technology to Enhance Care and Access to Treatment for Cirrhosis
Decompensated Cirrhosis
NCT07060079
Recruiting
The Use of Entropy to Assess Sleep Disordered Breathing in Chronic Respiratory Disease
Bronchial Asthma
NCT05405868 Phase 3
Recruiting
Nicotinamide in Glaucoma (NAMinG): A Randomised, Placebo-controlled, Multi-centre, Phase III Trial
Glaucoma, Open-Angle
NCT05604963
Recruiting
Hemithyroidectomy or Total-Thyroidectomy in 'Low-risk' Thyroid Cancers
Differentiated Thyroid Cancer
NCT02443831 Phase 1
Recruiting
CARPALL: Immunotherapy With CD19+CD22 CAR T-cells for CD19+ and CD22+ Acute Lymphoblastic Leukaemia
Acute Lymphoblastic Leukemia
NCT05655078
Recruiting
Hemithoracic Irradiation With Proton Therapy in Malignant Pleural Mesothelioma
Malignant Pleural Mesothelioma
NCT04106115 Phase 1, Phase 2
Recruiting
DURvalumab in Combination With S-488210/S-488211 vAccine in Non-muscle Invasive Bladder CancEr
Bladder Cancer
NCT02760108
Recruiting
Parkinson's Families Project
Parkinson's Disease
NCT04685616 Phase 3
Recruiting
Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
Hodgkin Lymphoma
NCT07024836
Recruiting
PRecision biomArker-Guided MAnagement of TuberculosIs Contacts: a Discrete Choice Experiment
Tuberculosis (TB)
NCT04795882 Phase 1
Recruiting
A New Study Evaluating the Activity of Modular CAR T for mYeloma
Multiple Myeloma
NCT05197322 Phase 2
Recruiting
NEOadjuvant PembRolizumab In Stratified Medicine - ColoRectal Cancer
Adenocarcinoma of the Colon
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology